Cancer therapy-related interstitial lung disease
Abstract. With the increasing utilization of cancer therapy, the incidence of lung injury associated with these treatments continues to rise. The recognition of pulmonary toxicity related to cancer therapy has become increasingly critical, for which interstitial lung disease (ILD) is a common cause...
Saved in:
Main Authors: | Chengzhi Zhou, Haiyi Deng, Yilin Yang, Fei Wang, Xinqing Lin, Ming Liu, Xiaohong Xie, Tao Luan, Nanshan Zhong, Peifang Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2025-02-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003149 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-PD-1 exacerbates bleomycin-induced lung injury in mice via Caspase-3/GSDME-mediated pyroptosis
by: Fei Wang, et al.
Published: (2025-01-01) -
A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma
by: Tao Luan, et al.
Published: (2024-12-01) -
Interstitial lung disease in rheumatic diseases
by: Sham Santhanam, et al.
Published: (2021-01-01) -
Granulomatous Lymphocytic Interstitial Lung Disease in Infancy
by: Adetayo Adeleye, et al.
Published: (2014-01-01) -
Assessment and follow-up of interstitial lung disease
by: Devarasetti Phani Kumar
Published: (2021-01-01)